We found than ATF5 exhibited the highest expression in malignant T cells, while it was also prominently detected in macrophages in CTCL microenvironment, whose clinical relevance remains largely unknown. Here, ATF5 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.